Raymond P. Ahlquist
Raymond P. Ahlquist (1914–1983) was a prominent pharmacologist who made significant contributions to the field of pharmacology. He is best known for his groundbreaking work on adrenergic receptors, which has had a profound impact on the understanding and treatment of cardiovascular diseases.
Early Life and Education[edit | edit source]
Raymond P. Ahlquist was born in 1914. He pursued his higher education at the University of Minnesota, where he received his PharmD degree. He later earned his PhD in Pharmacology from the same institution.
Career[edit | edit source]
Ahlquist began his career as a faculty member at the University of Georgia College of Pharmacy, where he conducted his seminal research on adrenergic receptors. His work led to the classification of these receptors into two main types: alpha and beta. This discovery has been instrumental in the development of many drugs used in the treatment of cardiovascular diseases.
Adrenergic Receptors[edit | edit source]
Ahlquist's research on adrenergic receptors led to the identification of two main types: alpha and beta. These receptors are found on the surface of cells in the heart, blood vessels, and other tissues and organs. They respond to the hormones epinephrine and norepinephrine, which are released by the adrenal glands. Ahlquist's classification of these receptors has been fundamental in understanding the physiological responses to these hormones and in the development of drugs that target these receptors.
Legacy[edit | edit source]
Ahlquist's work has had a profound impact on the field of pharmacology. His classification of adrenergic receptors has been fundamental in the development of many drugs used in the treatment of cardiovascular diseases. His contributions to the field have been recognized with numerous awards and honors, including the Lasker Award.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD